| |
| |
|
| Insider
Information: |
King Robert |
| Relationship: |
Chief Development Offi... |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
567,715 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,969,195 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
567,715 |
|
|
| Total
Value |
$2,969,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -120.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
SVP of Prod. Dev/Suppl... |
2016-08-12 |
16,844 |
|
0 |
Premium* |
|
|
Alector, Inc. |
ALEC |
Chief Development Offi... |
2022-10-01 |
550,871 |
2019-08-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2022-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,576 |
550,871 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2022-09-02 |
4 |
S |
$10.62 |
$1,869 |
D/D |
(176) |
529,295 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2022-06-02 |
4 |
S |
$8.71 |
$1,542 |
D/D |
(177) |
529,471 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2022-03-01 |
4 |
S |
$15.57 |
$4,468 |
D/D |
(287) |
528,404 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2021-12-01 |
4 |
S |
$20.09 |
$5,023 |
D/D |
(250) |
528,691 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2021-10-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,939 |
528,256 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,967 |
530,284 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2021-07-02 |
4 |
AS |
$31.14 |
$1,868,400 |
D/D |
(60,000) |
522,317 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2021-07-02 |
4 |
OE |
$8.16 |
$549,000 |
D/D |
60,000 |
582,317 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
522,317 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2020-05-15 |
4 |
AS |
$26.24 |
$404,958 |
D/D |
(15,000) |
477,317 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2020-02-14 |
4 |
AS |
$29.09 |
$443,376 |
D/D |
(15,000) |
492,317 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2019-11-15 |
4 |
AS |
$15.92 |
$119,400 |
D/D |
(7,500) |
522,317 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Chief Development Officer |
• – – |
2019-08-19 |
4 |
AS |
$15.00 |
$112,500 |
D/D |
(7,500) |
529,817 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
SVP of Prod. Dev/Supply Chain |
• – – |
2016-08-12 |
4 |
S |
$10.41 |
$506,623 |
D/D |
(48,667) |
16,844 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
SVP of Prod. Dev/Supply Chain |
• – – |
2016-08-12 |
4 |
OE |
$0.00 |
$210,935 |
D/D |
48,667 |
18,844 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
SVP of Prod Devp/ Supply Chain |
• – – |
2015-02-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,582 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
